Ersvaer, E., Kittang, A. O., Hampson, P., Sand, K., Gjertsen, B. T., Lord, J. M., & Bruserud, Ø. (2010). The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity. Molecular Diversity Preservation International.

Ersvaer, Elisabeth, Astrid Olsnes Kittang, Peter Hampson, Kristoffer Sand, Bjørn Tore Gjertsen, Janet M. Lord, and Øystein Bruserud. The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity. Molecular Diversity Preservation International, 2010.

Ersvaer, Elisabeth, et al. The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity. Molecular Diversity Preservation International, 2010.